11:16 AM EDT, 03/25/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1.39% to 1,731.11 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion ( EVAX ) , which rose 4.5% and 3.2% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and biopharmaceutical company Grifols (GRFS), which were up 2.8% and 2.2% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS ( EDAP ) , which fell 6.3% and 4.7% respectively. They were followed by internet browser company Opera (OPRA) and internet advertising firm Criteo ( CRTO ) , which were down 2.6% and 1% respectively.

The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which advanced 6% and 5% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Trinity Biotech ( TRIB ) , which increased 4.4% and 3.3% respectively.

The only decliners from the UK and Ireland were biopharmaceutical company NuCana ( NCNA ) and educational publisher Pearson (PSO), which dropped 1.9% and 0.7% respectively.